Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Latest HTA activities by the Scottish Health Technology Group

The Scottish Health Technologies Group (SHTG) is a national health technology assessment (HTA) agency providing advice to NHSScotland on the use of new and existing health technologies (excluding medicines), likely to have a significant impact on healthcare. NHSScotland is required to consider SHTG advice.

In July 2022, three publications were issued by SHTG:

  • KardiaMobile for detecting atrial fibrillation – an adaptation of NICE guidance from 2022. SHTG recommends single-lead KardiaMobile as an option for detecting atrial fibrillation (AF) for people with suspected paroxysmal AF who present with symptoms such as palpitations and are referred for ambulatory electrocardiogram (ECG) monitoring by a clinician;

SHTG is working on the following assessments related to medical procedures or technologies (as of August 5, 2022):

  • AI for reading chest X-Rays;
  • Outpatient biopsies (reusable and disposable) equipment for suspicious laryngeal and pharyngeal lesions;
  • Orthotic bracing for the treatment of children and young people (<18 years) with idiopathic scoliosis;
  • Therasphere and other selective internal radiation therapies for treating (SIRT) hepatocellular carcinoma (liver cancer);
  • Living Donor Transplantation.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).